This phenomenon was also observed in studies involving breast cancer patients, where healthy women exhibited increased levels of spontaneous T cell autoreactivity to HER-2, while women with breast cancer were found to lack this cellular response [52,53]. This evidence concerns the gene ERBB2 and breast carcinoma.